NCT01881802

Unknown

Study of Opioid Immunosuppressive Effects

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Source

Compare

Other study identifiers

Sponsor study identifier

01

Study Type

observational

Estimated enrollment

50

Locations

0 countries

Sites

N/A

Timeline

Study Start

March 2013

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

June 2013

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

Not reported

Date not reported

Brief Summary

This trial aims to investigate the effects of opioid-inducing immune suppression on opioid drug abused patients. The methods of the investigators research mainly includes the expression of morphine-related miRNAs in peripheral blood mononuclear cells and cytokine in plasma.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: unknown
Estimated enrollment: 50 participants
Study completion date: Not reported
Date not reported
Listed locations: 0 countries · 0 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
March 2013
Date type not reported
This date has not been verified as actual or estimated.
Primary Completion
June 2013
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
First Submitted
June 3, 2013
Actual (reported)
First Posted
June 20, 2013
Actual (reported)

Last Updated: June 20, 2013
Status Verified: June 2013
Last Update Submitted: June 19, 2013

Conditions

Opioid Abuse or Dependence

Keywords

Opioid drug AbuseMorphineImmune Function

Outcome Measures

Primary Outcomes (1)

real-time quantitative polymerase chain reaction
up to 2 months

Secondary Outcomes (1)

enzyme-linked immuno sorbent assay
up to 2 months

Study Arms (2)

morphine or heroin dependence patients

normal control group

Eligibility Criteria

Age18 Years - 55 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64)

Sampling MethodNon-Probability Sample

Study Population

Guangzhou Psychiatric Hospital

You may qualify if:

subjects were excluded if they had a chronic systemic illness (cardiac, renal, pulmonary, hepatic, endocrine, metabolic, or autoimmune disorders) or

Sponsors & Collaborators

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Otherlead

Biospecimen

Retention: SAMPLES WITH DNA

The refrigerator - 80 degrees

MeSH Terms

Conditions

Opioid-Related Disorders

Condition Hierarchy (Ancestors)

Narcotic-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: CROSS SECTIONAL
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: doctoral candidate

Study Record Dates

First Submitted

June 3, 2013

First Posted

June 20, 2013

Study Start

March 2013

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

June 2013

Estimated (date passed)

a major psychiatric disorder or

You may not qualify if:

Control subjects with no history of drug or alcohol abuse were also excluded if they had
major medical or psychiatric disorders

Contact the study team to confirm eligibility.

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated

June 20, 2013

Record last verified: 2013-06

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT01881802
Data provider: ClinicalTrials.gov
Source updated: 2013-06-20
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:36:30 UTC

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (2)

morphine or heroin dependence patients

normal control group

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Biospecimen

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Design

Study Record Dates

You may not qualify if:

Source record